CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-16 | McCracken Joseph S Director | Option exercise | +1,807 | $1.76 | $3K | 302,644 |
| 2026-02-16 | McCracken Joseph S Director | Option exercise · Stock Option (right to buy) | −1,807 | 0 | ||
| 2025-12-19 | RAMSAY DAVID A Director | Sale | −20,000 | $6.06 | $121K | 2,533,642 |
| 2025-12-16 | Lowrance David L Chief Financial Officer | Gift | −32,000 | 286,045 | ||
| 2025-12-16 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Gift | −128,995 | 1,188,050 | ||
| 2025-12-14 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −62,960 | $6.92 | $436K | 318,045 |
| 2025-12-14 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −195,705 | $6.92 | $1.4M | 1,317,045 |
| 2025-12-14 | Lutz Robert Matthew Chief Operating Officer | Shares withheld for taxes | −67,760 | $6.92 | $469K | 293,977 |
| 2025-12-14 | McCabe Kathleen R. Chief Legal Officer | Shares withheld for taxes | −39,350 | $6.92 | $272K | 519,232 |
| 2025-12-14 | Erickson Anne Chief Business Officer | Shares withheld for taxes | −62,960 | $6.92 | $436K | 371,712 |
| 2025-12-10 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Gift | −23,629 | 1,512,750 | ||
| 2025-12-09 | Hawkins Richard J Director | Grant or award | +40,000 | 161,326 | ||
| 2025-12-09 | van Es-Johansson An Director | Grant or award | +40,000 | 102,500 | ||
| 2025-12-09 | Elam Nevan C Director | Grant or award | +40,000 | 106,887 | ||
| 2025-12-09 | RAMSAY DAVID A Director | Grant or award | +40,000 | 2,553,642 | ||
| 2025-12-09 | McCracken Joseph S Director | Grant or award | +40,000 | 300,837 | ||
| 2025-12-04 | Wasfi Yasmine Chief Medical Officer | Shares withheld for taxes | −21,992 | $6.37 | $140K | 168,008 |
| 2025-12-02 | Elam Nevan C Director | Option exercise | +5,860 | $1.46 | $9K | 68,360 |
| 2025-12-02 | Elam Nevan C Director | Shares withheld for taxes | −1,473 | $5.81 | $9K | 66,887 |
| 2025-12-02 | Elam Nevan C Director | Option exercise · Stock Option (Right to Buy) | −5,860 | 0 |
Page 3 of 11 · 202 trades